News

360Dx – Proteomics International Presents Study Data Supporting PromarkerD Kidney Disease Test

Proteomics International presented results from the study this week in a poster at the Scientific Sessions of the American Diabetes Association. In an analysis of 3,000 subjects, the researchers found that patients identified as high-risk by the test were 13.5 times more likely than patients identified as low-risk to develop chronic kidney disease within the next four years. Patients identified as being at moderate risk were 5.3 times more likely to develop CKD than low-risk patients.

Article: Proteomics International Presents Study Data Supporting PromarkerD Kidney Disease Test

Subscribe
  • This field is for validation purposes and should be left unchanged.